Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

Scope of the Report:
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.
The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

The worldwide market for Pneumococcal Vaccine is expected to grow at a CAGR of roughly 1.0% over the next five years, will reach 7580 million US$ in 2024, from 7140 million US$ in 2019, according to a new WMR study.
This report focuses on the Pneumococcal Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Pfizer
GSK
MSD
Sanofipasteur
CDIBP

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
PPSV 23
PCV 7/13
PCV 10

Market Segment by Applications, can be divided into
Child
Adult

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine, with price, sales, revenue and global market share of Pneumococcal Vaccine in 2017 and 2018.
Chapter 3, the Pneumococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
1.1 Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 PPSV 23
1.2.2 PCV 7/13
1.2.3 PCV 10
1.3 Market Analysis by Applications
1.3.1 Child
1.3.2 Adult
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Pneumococcal Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GSK
2.2.1 Business Overview
2.2.2 Pneumococcal Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 MSD
2.3.1 Business Overview
2.3.2 Pneumococcal Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofipasteur
2.4.1 Business Overview
2.4.2 Pneumococcal Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 CDIBP
2.5.1 Business Overview
2.5.2 Pneumococcal Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pneumococcal Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Pneumococcal Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Pneumococcal Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Pneumococcal Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Pneumococcal Vaccine Market Analysis by Regions
4.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pneumococcal Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Pneumococcal Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
5 North America Pneumococcal Vaccine by Country
5.1 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Pneumococcal Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Pneumococcal Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
6 Europe Pneumococcal Vaccine by Country
6.1 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Pneumococcal Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Pneumococcal Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
6.4 France Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Pneumococcal Vaccine by Country
7.1 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Pneumococcal Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Pneumococcal Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
7.5 India Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
8 South America Pneumococcal Vaccine by Country
8.1 South America Pneumococcal Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Pneumococcal Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Pneumococcal Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Pneumococcal Vaccine by Countries
9.1 Middle East and Africa Pneumococcal Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pneumococcal Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Pneumococcal Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
10 Global Pneumococcal Vaccine Market Segment by Type
10.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Pneumococcal Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2014-2019)
10.2 PPSV 23 Sales Growth and Price
10.2.1 Global PPSV 23 Sales Growth (2014-2019)
10.2.2 Global PPSV 23 Price (2014-2019)
10.3 PCV 7/13 Sales Growth and Price
10.3.1 Global PCV 7/13 Sales Growth (2014-2019)
10.3.2 Global PCV 7/13 Price (2014-2019)
10.4 PCV 10 Sales Growth and Price
10.4.1 Global PCV 10 Sales Growth (2014-2019)
10.4.2 Global PCV 10 Price (2014-2019)
11 Global Pneumococcal Vaccine Market Segment by Application
11.1 Global Pneumococcal Vaccine Sales Market Share by Application (2014-2019)
11.2 Child Sales Growth (2014-2019)
11.3 Adult Sales Growth (2014-2019)
12 Pneumococcal Vaccine Market Forecast (2019-2024)
12.1 Global Pneumococcal Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Pneumococcal Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America Pneumococcal Vaccine Market Forecast (2019-2024)
12.2.2 Europe Pneumococcal Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Pneumococcal Vaccine Market Forecast (2019-2024)
12.2.4 South America Pneumococcal Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Pneumococcal Vaccine Market Forecast (2019-2024)
12.3 Pneumococcal Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global Pneumococcal Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global Pneumococcal Vaccine Market Share Forecast by Type (2019-2024)
12.4 Pneumococcal Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global Pneumococcal Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global Pneumococcal Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Pneumococcal Vaccine Picture
Table Product Specifications of Pneumococcal Vaccine
Figure Global Sales Market Share of Pneumococcal Vaccine by Types in 2018
Table Pneumococcal Vaccine Types for Major Manufacturers
Figure PPSV 23 Picture
Figure PCV 7/13 Picture
Figure PCV 10 Picture
Figure Pneumococcal Vaccine Sales Market Share by Applications in 2018
Figure Child Picture
Figure Adult Picture
Figure United States Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure France Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure UK Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure China Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure India Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Pneumococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Pneumococcal Vaccine Type and Applications
Table Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Pneumococcal Vaccine Type and Applications
Table GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table MSD Basic Information, Manufacturing Base and Competitors
Table MSD Pneumococcal Vaccine Type and Applications
Table MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table Sanofipasteur Pneumococcal Vaccine Type and Applications
Table Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CDIBP Basic Information, Manufacturing Base and Competitors
Table CDIBP Pneumococcal Vaccine Type and Applications
Table CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Pneumococcal Vaccine Sales by Manufacturer (2017-2018)
Figure Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Figure Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2018
Table Global Pneumococcal Vaccine Revenue by Manufacturer (2017-2018)
Figure Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Figure Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2018
Figure Top 3 Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Global Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Global Pneumococcal Vaccine Revenue and Growth Rate (2014-2019)
Table Global Pneumococcal Vaccine Sales by Regions (2014-2019)
Table Global Pneumococcal Vaccine Sales Market Share by Regions (2014-2019)
Table Global Pneumococcal Vaccine Revenue by Regions (2014-2019)
Figure Global Pneumococcal Vaccine Revenue Market Share by Regions in 2014
Figure Global Pneumococcal Vaccine Revenue Market Share by Regions in 2018
Figure North America Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Europe Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure South America Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure North America Pneumococcal Vaccine Revenue and Growth Rate (2014-2019)
Table North America Pneumococcal Vaccine Sales by Countries (2014-2019)
Table North America Pneumococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure North America Pneumococcal Vaccine Sales Market Share by Countries in 2014
Figure North America Pneumococcal Vaccine Sales Market Share by Countries in 2018
Table North America Pneumococcal Vaccine Revenue by Countries (2014-2019)
Table North America Pneumococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America Pneumococcal Vaccine Revenue Market Share by Countries in 2014
Figure North America Pneumococcal Vaccine Revenue Market Share by Countries in 2018
Figure United States Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Canada Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Mexico Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Europe Pneumococcal Vaccine Revenue and Growth Rate (2014-2019)
Table Europe Pneumococcal Vaccine Sales by Countries (2014-2019)
Table Europe Pneumococcal Vaccine Sales Market Share by Countries (2014-2019)
Table Europe Pneumococcal Vaccine Revenue by Countries (2014-2019)
Figure Europe Pneumococcal Vaccine Revenue Market Share by Countries in 2017
Figure Europe Pneumococcal Vaccine Revenue Market Share by Countries in 2018
Figure Germany Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure UK Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure France Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Russia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Italy Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Pneumococcal Vaccine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Pneumococcal Vaccine Sales by Countries (2014-2019)
Table Asia-Pacific Pneumococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Pneumococcal Vaccine Sales Market Share by Countries 2018
Table Asia-Pacific Pneumococcal Vaccine Revenue by Countries (2014-2019)
Figure Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Countries 2018
Figure China Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Japan Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Korea Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure India Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure South America Pneumococcal Vaccine Revenue and Growth Rate (2014-2019)
Table South America Pneumococcal Vaccine Sales by Countries (2014-2019)
Table South America Pneumococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure South America Pneumococcal Vaccine Sales Market Share by Countries in 2018
Table South America Pneumococcal Vaccine Revenue by Countries (2014-2019)
Table South America Pneumococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure South America Pneumococcal Vaccine Revenue Market Share by Countries in 2018
Figure Brazil Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Argentina Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Colombia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Pneumococcal Vaccine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Pneumococcal Vaccine Sales by Countries (2014-2019)
Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries in 2018
Table Middle East and Africa Pneumococcal Vaccine Revenue by Countries (2014-2019)
Table Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries in 2014
Figure Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure UAE Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Egypt Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Nigeria Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Figure South Africa Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
Table Global Pneumococcal Vaccine Sales by Type (2014-2019)
Table Global Pneumococcal Vaccine Sales Share by Type (2014-2019)
Table Global Pneumococcal Vaccine Revenue by Type (2014-2019)
Table Global Pneumococcal Vaccine Revenue Share by Type (2014-2019)
Figure Global PPSV 23 Sales Growth (2014-2019)
Figure Global PPSV 23 Price (2014-2019)
Figure Global PCV 7/13 Sales Growth (2014-2019)
Figure Global PCV 7/13 Price (2014-2019)
Figure Global PCV 10 Sales Growth (2014-2019)
Figure Global PCV 10 Price (2014-2019)
Table Global Pneumococcal Vaccine Sales by Application (2014-2019)
Table Global Pneumococcal Vaccine Sales Share by Application (2014-2019)
Figure Global Adult Sales Growth (2014-2019)
Figure Global Pneumococcal Vaccine Sales, Revenue and Growth Rate (2019-2024)
Table Global Pneumococcal Vaccine Sales Forecast by Regions (2019-2024)
Table Global Pneumococcal Vaccine Market Share Forecast by Regions (2019-2024)
Figure North America Sales Pneumococcal Vaccine Market Forecast (2019-2024)
Figure Europe Sales Pneumococcal Vaccine Market Forecast (2019-2024)
Figure Asia-Pacific Sales Pneumococcal Vaccine Market Forecast (2019-2024)
Figure South America Sales Pneumococcal Vaccine Market Forecast (2019-2024)
Figure Middle East and Africa Sales Pneumococcal Vaccine Market Forecast (2019-2024)
Table Global Pneumococcal Vaccine Sales Forecast by Type (2019-2024)
Table Global Pneumococcal Vaccine Market Share Forecast by Type (2019-2024)
Table Global Pneumococcal Vaccine Sales Forecast by Application (2019-2024)
Table Global Pneumococcal Vaccine Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

Global Cold Chain Equipment Market (2024 Edition): Analysis By Equipment Type (Refrigerators, Deep Freezers & Reefer Containers, Cold Boxes & Vaccine Carriers, Cold Rooms/ Chillers, Other Equipment Types), By Purpose, By End-use, By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...

Global Vaccine Supply Chain Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Vaccine Supply Chain Solutions Market: The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...

Global Digital Vaccine Tracking System Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Digital Vaccine Tracking System Market: The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity...

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...

2023-2028 Global and Regional Whole Cell Cholera Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

2023-2028 Global and Regional Viral Vaccine Media Industry Status and Prospects Professional Market Research Report Standard Version...

The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...

2023-2028 Global and Regional Vero Cell Rabies Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Vero Cell Rabies Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...